208 related articles for article (PubMed ID: 34498388)
1. The bioequivalence of fixed-dose combination tablets of bisoprolol and ramipril and its drug-drug interaction potential.
Sus J; Huguet J; Bosak J; Setnik B; Hauser T; Sicard E
Clin Transl Sci; 2022 Jan; 15(1):158-171. PubMed ID: 34498388
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence and Pharmacokinetics of Bisoprolol-Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects.
Hu C; Hu X; Wang C; Zhao Z; Gao D; Chen X; Zhou D; Huang Y; Li L; Zhang L
Clin Drug Investig; 2018 Dec; 38(12):1145-1154. PubMed ID: 30232699
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and concomitant administration of sitagliptin and metformin in healthy adult subjects: a randomized, open-label, crossover study.
Migoya EM; Miller JL; Gutierrez M; Zheng W; Johnson-Levonas AO; Liu Q; Matthews CZ; Wagner JA; Gottesdiener KM
Clin Drug Investig; 2010; 30(12):855-66. PubMed ID: 20923244
[TBL] [Abstract][Full Text] [Related]
4. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence and food effect of a fixed-dose combination of macitentan and tadalafil: Adaptive design in the COVID-19 pandemic.
Csonka D; Fishman V; Natarajan J; Stieltjes H; Armas D; Dishy V; Perez Ruixo JJ
Pharmacol Res Perspect; 2021 Oct; 9(5):e00846. PubMed ID: 34624174
[TBL] [Abstract][Full Text] [Related]
6. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
[TBL] [Abstract][Full Text] [Related]
8. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence study of two tablet formulations of ramipril in healthy volunteers.
Allegrini A; Nuzzo L; Zucchelli M; Tavella-Scaringi A; Bucci M; Pavone D; Toniato E; Mezzetti A; Martinotti S; Bonani S
Arzneimittelforschung; 2009; 59(8):392-6. PubMed ID: 19813461
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers.
Hedaya MA; Helmy SA
Clin Ther; 2013 Jun; 35(6):846-61. PubMed ID: 23795576
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence study of 2 formulations of film-coated tablets containing a fixed dose combination of bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg in healthy subjects.
Tjandrawinata RR; Setiawati E; Yunaidi DA; Santoso ID; Setiawati A; Susanto LW
Drug Res (Stuttg); 2013 May; 63(5):243-9. PubMed ID: 23539427
[TBL] [Abstract][Full Text] [Related]
12. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.
Fortin A; Verbeeck RK; Jansen FH
Eur J Clin Pharmacol; 2011 Mar; 67(3):267-75. PubMed ID: 20949263
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Considerations About an Unexpected Ramipril Drug-Drug Interaction in the Development of a Triple Fixed-Dose Combination Product Containing Ramipril, Amlodipine, and Atorvastatin.
Hermann R; Gundlach K; Seiler D
Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1307-1315. PubMed ID: 33773093
[TBL] [Abstract][Full Text] [Related]
14. Comparative bioavailability of two ramipril formulations after single-dose administration in healthy volunteers.
Mendes GD; Dantas Sanfelice AT; do Carmo Borges NC; Cavedal LE; Sverdloff C; Prado Galuppo M; Módolo JH; De Nucci G
Int J Clin Pharmacol Ther; 2006 Feb; 44(2):93-8. PubMed ID: 16502769
[TBL] [Abstract][Full Text] [Related]
15. Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin : randomized, single-blind, three-period crossover study in healthy subjects.
Hoelscher D; Chu PL; Lyness W
Clin Drug Investig; 2008; 28(9):573-82. PubMed ID: 18666804
[TBL] [Abstract][Full Text] [Related]
16. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
Chang M; Liu X; Cui D; Liang D; LaCreta F; Griffen SC; Lubin S; Quamina-Edghill D; Boulton DW
Clin Ther; 2015 Jul; 37(7):1517-28. PubMed ID: 26048185
[TBL] [Abstract][Full Text] [Related]
18. Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes.
Lingvay I; Beetz N; Sennewald R; Schuler-Metz A; Bertulis J; Loley C; Lang B; Lippert C; Lee J; Manning LS; Terada D
Postgrad Med; 2020 May; 132(4):337-345. PubMed ID: 32366156
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence study of 2.5 mg film-coated bisoprolol tablets in healthy volunteers.
Buś-Kwaśnik K; Rudzki PJ; Ksycińska H; Leś A; Serafin-Byczak K; Raszek J; Bielak A; Wybraniec A; Płatek AE; Szymański FM; Łazowski T
Kardiol Pol; 2017; 75(1):48-54. PubMed ID: 27391910
[TBL] [Abstract][Full Text] [Related]
20. Investigation of bioequivalence of a new fixed-dose combination of nifedipine and candesartan with the corresponding loose combination as well as the drug-drug interaction potential between both drugs under fasting conditions.
Brendel E; Weimann B; Dietrich H; Froede C; Thomas D
Int J Clin Pharmacol Ther; 2013 Sep; 51(9):753-62. PubMed ID: 23849325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
